The Oncology Centre (Adults)


KFSH&RC enjoys the recognition of having the largest cancer facility in the Gulf region where more than 2,691 new patients were treated in 2013. The Centre was established with a mission of providing excellent cancer treatment, education and research; and it has evolved over the years moving closer towards its vision of becoming one of the best international centers for cancer research, prevention and treatment. The Center was accredited by the World Health Organization (WHO) as a Collaborating Centre for Cancer Prevention and Control, where cancer patients are assessed in multidisciplinary clinics and provided with treatment in accordance with disease-specific internationally accepted management guidelines. 

Our oncologists continue to actively address national oncology problems through their involvement in institutional, national, and international research protocols with the valuable support of the Oncology Research Unit (ORU) which also serves as a hospital base for cancer and bone marrow transplantation registries.
Innovation/New Services:          

  1. The Intra-Operative Radiation Therapy Program 
  2. The Tomo Therapy, Cyberknife and 3 fully operational linear accelerators with a wide range of photo and electron energies and imaging techniques.

State-of-the-art Technology:    

Implementation of latest clinical practices for advancement of radiation therapy treatments that are both current and evidence based.

Technology Advancement:

Introduction of a new technique in radiation therapy - deep inspiration breath hold (DIBH) is a cardiac sparing technique to treat left-sided breast cancer.


Maintaining affiliation with:                                                                                                                                     

  1. South West Oncology Group (SWOG)
  2. Radiation Therapy Oncology Group (RTOG)
  3. Center for International Blood and Marrow Transplant Research (CBMTR)
  4. European Group for Blood and Marrow Transplantation (EBMT); and the Hospital as its main secretariat.
  5. Medical Physics IAEA conference and training.
  6. Use of Gold plaques Iodine 125 brachytherapy treatment for eye tumor in collaboration with King Khaled Eye Specialist Hospital and King Abdulaziz University Hospital.
  7. King Saud University students’ orientation in radiation therapy services.
  8. Students of preparatory program in Radiological Sciences from Loma Linda University, Riyadh.


Adult Hematology HSCT Section

Our Hematopoietic Stem Cell Transplant Program (HSCT), is an internationally renowned leader in the blood and marrow transplantation for more than 32 years. In that time, HSCT has become an accepted, curative therapy for a broad range of diseases, including malignant diseases that involve the bone marrow such as Leukemias and Lymphomas, nonmalignant diseases that involve the bone marrow such as Aplastic Anemia and a variety of inherited diseases.
To date, over 5,100 bone marrow transplants have been performed at the Oncology Centre, that is fully accredited by the National Marrow Donor Program as an unrelated donor transplant center.


Medical Oncology

The aim of the Medical Oncology is the accurate diagnosis and optimum management of cancer. The consultants provide consultative advice on the clinical care of cancer patients, and are involved in both clinical and basic research pertaining to cancer. The medical oncology has very competitive fellowship program for training finest oncologist for future needs of the Kingdom.

This section is involved in myriad of national and international clinical research trials on chemotherapy, combined modality therapies and targeted therapies.


Palliative Care Medicine

Palliative Care team aims at the assessment and management of physical and psychological problems experienced by both patients with advanced cancer and their families. About 50% of patients who receive a diagnosis of cancer experience these intricate and overwhelming problems.  

Palliative Care is a multidisciplinary approach aimed at enhancing quality of life of cancer patients by providing comprehensive medical and psychosocial screening, diagnosis and treatment to cancer patients. Our mission is to integrate palliative care throughout all sections, in clinical practice, research and education. The Oncology Centre consultants are collaborating with other services to provide interdisciplinary consultation services, post-graduate medical education, and palliative care research programs. Consultants and fellows are involved in teaching and research focused on multi-dimensional assessment of physical and psychosocial symptoms, as well as on pharmacological and non-pharmacological treatment modalities. Some of the sponsored research programs include comparing alternative medicine and spirituality on health and long term outcome of terminally ill patients and their families.

Read more



Radiation Oncology

Research Unit

The Oncology Centre Research Unit, managed by a Head, Supervisor and support staff, comprises of three sub-units which offer unique services relevant to each area.

  • Clinical Research
  • Tumor Registry
  • Progenitor Stem Cell Transplant Program (PSCTP)

Clinical Research section is responsible for assisting Oncology Centre physicians and authorized others with the design of clinical research projects including the development of the database, data collection, data management and analysis of clinical data in accordance with Research Advisory Council guidelines.

      The Clinical Research Area offers the following services:

  • Actively participate in the coordination of in-house and international trials following Research Advisory
    Council guidelines.
  • Identify data elements for clinical research studies.
  • Design or assist with design of the Clinical Research Form.
  • Develop appropriate database for clinical research project.
  • Identify patients for inclusion into the clinical research study and request medical records.
  • Abstract pertinent data for entry into the database.
  • Provide specific descriptive epidemiology of cancer disease.
  • Perform data survival analysis.
  • Provide graphic presentation of data.
  • Assist with proposal development before submission to appropriate regulatory committees.

Tumor Registry is a pivotal function of the cancer program by providing definitive information concerning the nature and extent of the hospital’s experience in diagnosing and treating cancer. The Tumor Registry maintains a comprehensive database of all patients referred to King Faisal Specialist Hospital and Research Centre since 1975 with a malignant disease process, including cases seen at King Fahad National Children’s Cancer Centre. In addition, minimal information on neoplasms of uncertain behavior and benign brain tumors is abstracted from patient records and entered into the database. The Tumor Registry also produces an Annual Report for distribution throughout the hospital.

       Tumor Registry Annual Report:

      2014 Report

       The Tumor Registry offers the following services:

  • Identify patients with one or more malignant diagnoses.
  • Differentiate between most common malignancies by site or histology.
  • On request, generate lists of specific cases by selected criteria (variables).
  • Provide treatment information for a particular diagnosis.
  • Produce statistical and/or descriptive information for cases using demographic factors.
  • Show trends of certain disease categories over a given period.

      Cancer Registery Staging Forms

Progenitor Stem Cell Transplant Program (PSCTP) is a vital section responsible for the accrual of patients to be included in the King Faisal Specialist Hospital and Research Centre’s Bone Marrow Transplant Program database. It reports the hospital’s cases to the International Bone Marrow Transplant Registry (CIBMTR) and European Society for Blood and Marrow Transplantation (EBMT).

      The Progenitor Stem Cell Transplant Program offers the following services:           

  • Registration of patients in the International Bone Marrow Transplant Program.
  • Identification of appropriate data elements for both allogeneic and autologous Progenitor Stem Cell Transplant Programs as requested.
  • Design and development of databases for Progenitor Stem Cell Transplant Programs
  • Preparation of approved treatment protocols.
  • Produce follow-up information on study patients.
  • Database management for procurement of protocol data as requested for use in local prospective and retrospective research studies.
  • Assist with development of clinical research proposals using RAC guidelines, before submission to appropriate regulatory committees.